AGP Picks
View all

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on November 12, 2026

Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Altimmune Announces Third Quarter 2026 Financial Results and Business Update
Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16
Immuneering Announces New Potentially Registrational Phase 2 Trial Evaluating Atebimetinib with Chemotherapy in Anaplastic Thyroid Cancer
TSX Opening and Chibougamau Project Update
Ouverture des marchés de la TSX et mise à jour sur le projet Chibougamau
ZenaTech’s ZenaDrone Signs MOU with Rattler Medical to Develop Drone-Based Battlefield Blood Delivery System
Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update
HydroGraph Receives Final Court Order Approving Redomicile Transactions
Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Immuneering to Collaborate with Astellas on Clinical Studies of Investigational CLDN18.2 Programs in Combination with Atebimetinib for Pancreatic Cancer Patients
Vor Bio Expands Strategic Partnership with RemeGen, Adding Next Generation, Long-Acting RC298 to BAFF/APRIL Franchise
Drones Drive Strong ENVX Revenue Growth
MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth
Dyadic’s C1-Produced RSV and Malaria Antibodies Advance into Animal Studies Following Positive Independent Evaluations
Ascendis Pharma Reports Third Quarter 2026 Financial Results
Quantum X Labs Joins the Global Race by Publishing Updated Execution Roadmap for Building its Cold-Atom Quantum Computer, Targeting Fault-Tolerant Computing by 2030
Generate Biomedicines Reports Third Quarter 2026 Financial Results and Provides Business Update
Altimmune Announces Publication of IMPACT Phase 2b 48-Week Data in MASH in The Lancet Gastroenterology & Hepatology

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

STEM News Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.